NasdaqCM:BTBT
NasdaqCM:BTBTSoftware

Assessing Bit Digital (BTBT) Valuation As Earnings Forecasts Show Smaller Loss And Revenue Growth

Why Bit Digital (BTBT) is on investors’ radar right now Bit Digital (BTBT) is drawing attention as it heads into an earnings report, where the company is expected to post a loss of $0.02 per share and 17.48% revenue growth year over year. See our latest analysis for Bit Digital. Bit Digital’s recent trading has been choppy, with a 7.46% 1 month share price return and a 38.98% 3 month share price decline. Its 1 year total shareholder return of 29.18% and 3 year total shareholder return of 35%...
NasdaqGS:BYND
NasdaqGS:BYNDFood

Beyond Meat Lawsuits Put Asset Values And Investor Confidence Under Scrutiny

Securities class action lawsuits have been filed against Beyond Meat, alleging false and misleading statements about the valuation of its long lived assets. Plaintiffs claim the company did not promptly disclose the need for a substantial non cash impairment charge. The cases focus on the accuracy and timing of Beyond Meat’s financial disclosures to shareholders. For investors watching NasdaqGS:BYND, these lawsuits put the spotlight firmly on Beyond Meat’s balance sheet and reporting...
NasdaqGS:EXC
NasdaqGS:EXCElectric Utilities

ComEd’s Grid Plan And Clean Energy Push Might Change The Case For Investing In Exelon (EXC)

In 2025, Exelon subsidiary ComEd advanced its efforts to serve more than 9 million people in northern Illinois by maintaining nation-leading electric reliability, connecting tens of thousands of customers to renewable energy resources, and delivering over US$500,000,000 in rebates and energy efficiency savings for technologies such as EVs, solar, and battery storage. ComEd also introduced over US$100,000,000 in new energy relief programs and, in January 2026, filed a multiyear grid plan...
NYSE:XOM
NYSE:XOMOil and Gas

Does ExxonMobil’s Carbon Capture Push And Asset Sales Recast Its Core Investment Story For XOM?

In recent weeks, ExxonMobil has advanced its energy transition strategy by expanding carbon capture and storage projects along the U.S. Gulf Coast and moving to sell XTO Energy assets in the Eagle Ford shale basin. This combination of growing low-carbon infrastructure and concentrating on core producing regions highlights how ExxonMobil is reshaping its portfolio mix around different types of energy assets. Next, we will examine how this push into carbon capture, alongside portfolio...
NasdaqCM:RKLB
NasdaqCM:RKLBAerospace & Defense

Rocket Lab Neutron Fairing Breakthrough And Test Setback Reframe Reuse Ambitions

Rocket Lab (NasdaqCM:RKLB) delivered its world first "Hungry Hippo" reusable fairing to the Neutron launch site, introducing a captive fairing design aimed at quicker rocket reuse. The company is progressing Neutron qualification after a Stage 1 tank rupture during testing, treating the event as part of its development roadmap. Both milestones arrive during an important build out phase for Neutron, which targets the medium lift launch segment with a reusable architecture. For you as an...
NYSE:APH
NYSE:APHElectronic

Amphenol (APH) Earnings Surge 76.2% Challenges Concerns Over Lofty P/E Multiple

Amphenol (APH) closed out FY 2025 with fourth quarter revenue of US$6.4b and basic EPS of US$0.98, alongside trailing twelve month revenue of US$23.1b and EPS of US$3.51 that reflect the latest run rate for the business. The company has seen revenue move from US$4.3b in Q4 2024 to US$6.4b in Q4 2025, with trailing twelve month EPS rising over the same window from US$2.01 to US$3.51, and those results sit against trailing earnings growth of 76.2% and forecast revenue growth of about 14.7% per...
NasdaqGS:RPRX
NasdaqGS:RPRXPharmaceuticals

Assessing Royalty Pharma (RPRX) Valuation After Teva Autoimmune Funding Partnership Attracts Fresh Attention

Why Royalty Pharma’s latest funding deal matters Royalty Pharma (RPRX) has moved into focus after announcing a funding partnership with Teva Pharmaceuticals to speed up clinical development of an anti IL 15 antibody for autoimmune diseases. This agreement highlights how Royalty Pharma deploys capital into biopharma projects, with investors watching how the Teva collaboration fits into its existing portfolio of marketed therapies and development stage candidates. See our latest analysis for...
NYSE:FAF
NYSE:FAFInsurance

A Look At First American Financial’s Valuation After Recent Share Price Momentum

Recent share performance and business backdrop First American Financial (FAF) has attracted attention after its recent share performance, with the stock last closing at $63.81 and total return figures available across the past month and past 3 months. See our latest analysis for First American Financial. While the latest 1 day share price return of 1.42% was negative, First American Financial’s 30 day share price return of 2.77% and year to date share price return of 4.47% sit alongside a 1...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Assessing CRISPR Therapeutics (CRSP) Valuation After Recent Share Price Movements

Recent performance context for CRISPR Therapeutics (CRSP) CRISPR Therapeutics (CRSP) has drawn attention after a mixed stretch in its share performance, including a modest move over the past month and a decline in the past 3 months from recent levels. See our latest analysis for CRISPR Therapeutics. At a latest share price of US$53.69, CRISPR Therapeutics has seen weaker momentum recently, with a 90 day share price return of 12.13% and a 1 year total shareholder return of 30.28%, while the 5...
NYSE:BROS
NYSE:BROSHospitality

Dutch Bros (BROS) Is Down 6.1% After Citi Coverage Highlights Youthful Brand Momentum And Expansion Plans – Has The Bull Case Changed?

Dutch Bros has recently drawn attention as Citi initiated coverage praising its strong brand momentum, youthful customer base, and long-term expansion ambitions, alongside moves into retail coffee products and continued store openings. An interesting angle for investors is how Dutch Bros’ focus on younger consumers and at-home products could deepen brand engagement beyond its drive-thru shops. We’ll now explore how Citi’s focus on Dutch Bros’ brand momentum and youth appeal shapes the...
NasdaqGS:TMC
NasdaqGS:TMCMetals and Mining

TMC Expands NOAA Seabed Bid As Project Shifts Toward Commercial Phase

TMC the metals (NasdaqGS:TMC) has filed a new application with the US National Oceanic and Atmospheric Administration to expand its Clarion Clipperton Zone area for deep sea exploration and commercial recovery. The requested area is more than twice the size of TMC's prior US application, reflecting a larger project scope under prospective US regulatory oversight. The filing follows over a decade of scientific, engineering, and environmental work by the company and marks a step toward...
NYSE:GEV
NYSE:GEVElectrical

Is It Too Late To Consider GE Vernova (GEV) After Its 102% One Year Rally?

If you are wondering whether GE Vernova's share price still offers value after its recent run, the key question is how the current price compares with a measured view of what the business might be worth. The stock last closed at US$711.59, with returns of 6.5% over the past 7 days, 7.3% over the last month and 101.9% over the past year. This naturally raises questions about growth potential and changing risk perceptions. Recent coverage has focused on GE Vernova as a separate, pure play...
NasdaqGS:FAST
NasdaqGS:FASTTrade Distributors

Fastenal Highlights Digital And Large Customers As Valuation And Risks Weighed

Fastenal (NasdaqGS:FAST) recently highlighted a growing focus on large, contract-style customers and digital channels during its latest quarterly update. Nearly half of Q4 sales were tied to digital solutions, including e-commerce and inventory management programs, pointing to deeper integration with customers. Management framed these shifts as part of a longer term change in how the company serves industrial clients facing a slower demand backdrop. Fastenal, trading at $43.62, sits at the...
NasdaqGS:AGNC
NasdaqGS:AGNCMortgage REITs

AGNC Investment (AGNC) Valuation Check After Strong Recent Returns And Overvalued Fair Value Estimate

Why AGNC Investment is on income investors’ radar AGNC Investment (AGNC) has been drawing attention after recent share price moves, with the stock showing different return figures across the past week, month, past 3 months and year. That naturally raises questions about how its mortgage focused REIT model stacks up today. See our latest analysis for AGNC Investment. With the share price at US$12.02, AGNC Investment has recently posted a 20.20% 3 month share price return and a 41.74% 1 year...
NasdaqGS:CBC
NasdaqGS:CBCBanks

Central Bancompany (CBC) Net Interest Margin Gain Tests Bullish Profitability Narrative

Central Bancompany (CBC) just wrapped up FY 2025 with Q4 revenue of US$269.2 million and basic EPS of US$0.47, alongside trailing twelve month revenue of US$1.0 billion and EPS of US$1.76 that follow a year in which earnings rose 27.9% and revenue grew 8%. Over the past year, revenue has moved from US$883.1 million to US$1.0 billion while EPS has increased from US$1.39 to US$1.76, setting up this result against a backdrop of higher net profit margins and earnings that are described as high...
NasdaqGS:APLD
NasdaqGS:APLDIT

Applied Digital’s Delta Forge 1 Puts AI Data Center Thesis To Test

Applied Digital (NasdaqGS:APLD) has broken ground on its Delta Forge 1 AI data center campus, a new facility backed by long term lease agreements and a multibillion dollar backlog. The company is a key infrastructure partner for CoreWeave, which recently received a $2b investment from Nvidia that supports demand for Applied Digital's services. These developments have renewed attention on Applied Digital's role in the AI data center build out and its contracted revenue visibility. Applied...
NasdaqGS:ADI
NasdaqGS:ADISemiconductor

Assessing Analog Devices (ADI) Valuation After Strong Fiscal 2025 Results And Growing AI Exposure

Analog Devices (ADI) has been in focus after reporting fiscal 2025 results that featured 17% revenue growth, higher operating margins at 41.9%, and record free cash flow of US$4.3b, along with increasing attention on its AI related exposure. See our latest analysis for Analog Devices. The strong fiscal 2025 update and fresh AI focus sit alongside a 36.38% 90 day share price return and a 53.81% 1 year total shareholder return, suggesting momentum has been building as board changes, shareholder...
NYSE:AIT
NYSE:AITTrade Distributors

Applied Industrial Technologies (AIT) Valuation Check After Recent Share Price Pause

Recent share performance and business profile Applied Industrial Technologies (AIT) has been relatively steady over the past 3 months, with the stock showing a small positive total return despite weaker performance over the month and year to date. For context, the company reports annual revenue of US$4,754.03m and net income of US$403.79m, reflecting its role as a large distributor of industrial motion, power, control, and automation technology solutions across multiple regions. See our...
NYSE:DIS
NYSE:DISEntertainment

Assessing Walt Disney (DIS) Valuation As Recent Share Price Declines Clash With Conflicting Fair Value Signals

How Walt Disney stock has been trading Walt Disney (DIS) has seen its share price close at US$109.56, with recent returns showing a 0.9% decline over the past day and a 3.2% decline over the past week. Over a month, the stock shows a 4.1% decline, while the past 3 months reflect a 2.0% decline. On a year to date basis, Walt Disney records a 2.0% decline, with a 2.1% total return decline over the past year. Looking further back, the total return over 3 years stands at 2.5%, while the 5 year...
NYSE:OSCR
NYSE:OSCRInsurance

CMS Proposals Test Oscar Health’s Tech Heavy Insurance Model

The Centers for Medicare & Medicaid Services have proposed a smaller-than-expected payment rate increase for Medicare Advantage programs. CMS is also tightening risk-adjustment rules that affect how plans are paid based on members' health status. These proposals may influence Oscar Health's use of virtual care and data-driven coding, with potential effects on its cost structure. Oscar Health (NYSE:OSCR) is in focus as investors weigh how these CMS proposals could interact with its tech...
NYSE:DE
NYSE:DEMachinery

Does Deere (DE) Offer Value After Recent Share Price Strength And Industry Headlines?

If you are wondering whether Deere's current share price reflects its true worth, you are not alone. This article will walk through what the numbers are actually saying about value. Deere's stock recently closed at US$525.01, with returns of 11.6% over the last 30 days and 12.5% year to date, while the 1 year return sits at 11.3%. Over the past few months, Deere has been in the news for its role in global agriculture and construction equipment markets. Investors are paying close attention to...
NasdaqGS:CMPR
NasdaqGS:CMPRCommercial Services

Is Cimpress (CMPR) Offering Value After Mixed Short And Long Term Share Price Moves?

If you are wondering whether Cimpress at around US$77.91 is offering good value or asking too much, you are not alone in asking that question right now. The share price has had a mixed recent run, with a 2.7% decline over the last 7 days, a 12.9% gain over 30 days, 18.7% year to date, 5.0% over 1 year, a very large 3 year return of 121.5% and a 5 year return of 18.0% decline. These swings have kept Cimpress on the radar for investors who pay attention to how sentiment can shift over weeks...
NasdaqGS:WAFD
NasdaqGS:WAFDBanks

A Look At WaFd’s (WAFD) Valuation After Its Regulatory Upgrade And Expansion Plans

WaFd (WAFD) is back in focus after regulators upgraded the bank’s rating, reversing a prior “needs to improve” assessment and clearing the way for its planned expansion, a key development for shareholders. See our latest analysis for WaFd. Despite a modest 1-day share price decline of 0.22% and a 7-day share price decline of 2.02%, WaFd’s 90-day share price return of 9.19% and 1-year total shareholder return of 11.74% suggest momentum has been building around the upgraded regulatory rating,...
NasdaqGS:CRWV
NasdaqGS:CRWVIT

NVIDIA’s US$2b CoreWeave Bet Balances AI Growth And Legal Risks

NVIDIA announced a US$2b investment in CoreWeave (NasdaqGS:CRWV), along with an expanded partnership to support AI infrastructure buildout. The company is facing multiple class action lawsuits that claim CoreWeave overstated its capacity to meet customer demand and revenue commitments. These developments highlight both increased backing from a major AI chip supplier and rising legal risk around CoreWeave’s infrastructure disclosures. CoreWeave is an AI focused cloud provider that offers GPU...